Paul Hartmann AG

DB:PHH2 Voorraadrapport

Marktkapitalisatie: €694.4m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Paul Hartmann Inkomsten in het verleden

Verleden criteriumcontroles 4/6

De winst van Paul Hartmann is gedaald met een gemiddeld jaarlijks percentage van -17.7%, terwijl de winst van de Medical Equipment -industrie jaarlijks daalde met 1.1%. De inkomsten zijn groeide met een gemiddeld percentage van 1.1% per jaar. Het rendement op het eigen vermogen Paul Hartmann bedraagt 5.7% en de nettomarge bedraagt 2.5%.

Belangrijke informatie

-17.7%

Groei van de winst

-17.7%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie4.3%
Inkomstengroei1.1%
Rendement op eigen vermogen5.7%
Nettomarge2.5%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit

Mar 25
Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit

Recent updates

Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit

Mar 25
Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit

Calculating The Fair Value Of Paul Hartmann AG (FRA:PHH2)

Mar 08
Calculating The Fair Value Of Paul Hartmann AG (FRA:PHH2)

Getting In Cheap On Paul Hartmann AG (FRA:PHH2) Is Unlikely

Jan 31
Getting In Cheap On Paul Hartmann AG (FRA:PHH2) Is Unlikely

Paul Hartmann (FRA:PHH2) Has A Somewhat Strained Balance Sheet

Nov 16
Paul Hartmann (FRA:PHH2) Has A Somewhat Strained Balance Sheet

The Returns On Capital At Paul Hartmann (FRA:PHH2) Don't Inspire Confidence

Jul 05
The Returns On Capital At Paul Hartmann (FRA:PHH2) Don't Inspire Confidence

Is Paul Hartmann (FRA:PHH2) A Risky Investment?

May 06
Is Paul Hartmann (FRA:PHH2) A Risky Investment?

Paul Hartmann's (FRA:PHH2) Returns On Capital Not Reflecting Well On The Business

Jan 07
Paul Hartmann's (FRA:PHH2) Returns On Capital Not Reflecting Well On The Business

Here's What's Concerning About Paul Hartmann's (FRA:PHH2) Returns On Capital

Sep 03
Here's What's Concerning About Paul Hartmann's (FRA:PHH2) Returns On Capital

Here's Why Paul Hartmann (FRA:PHH2) Can Manage Its Debt Responsibly

Apr 02
Here's Why Paul Hartmann (FRA:PHH2) Can Manage Its Debt Responsibly

Paul Hartmann (FRA:PHH2) Shareholders Will Want The ROCE Trajectory To Continue

Mar 09
Paul Hartmann (FRA:PHH2) Shareholders Will Want The ROCE Trajectory To Continue

Is Paul Hartmann (FRA:PHH2) Using Too Much Debt?

Nov 24
Is Paul Hartmann (FRA:PHH2) Using Too Much Debt?

There's Been No Shortage Of Growth Recently For Paul Hartmann's (FRA:PHH2) Returns On Capital

May 19
There's Been No Shortage Of Growth Recently For Paul Hartmann's (FRA:PHH2) Returns On Capital

We Think Paul Hartmann (FRA:PHH2) Can Manage Its Debt With Ease

Apr 12
We Think Paul Hartmann (FRA:PHH2) Can Manage Its Debt With Ease

Should You Buy Paul Hartmann AG (FRA:PHH2) For Its Dividend?

Mar 25
Should You Buy Paul Hartmann AG (FRA:PHH2) For Its Dividend?

Does Paul Hartmann's (FRA:PHH2) Share Price Gain of 29% Match Its Business Performance?

Feb 24
Does Paul Hartmann's (FRA:PHH2) Share Price Gain of 29% Match Its Business Performance?

Paul Hartmann AG's (FRA:PHH2) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 03
Paul Hartmann AG's (FRA:PHH2) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

We're Watching These Trends At Paul Hartmann (FRA:PHH2)

Dec 29
We're Watching These Trends At Paul Hartmann (FRA:PHH2)

How Does Paul Hartmann AG (FRA:PHH2) Fare As A Dividend Stock?

Dec 11
How Does Paul Hartmann AG (FRA:PHH2) Fare As A Dividend Stock?

If You Had Bought Paul Hartmann's (FRA:PHH2) Shares Three Years Ago You Would Be Down 16%

Nov 23
If You Had Bought Paul Hartmann's (FRA:PHH2) Shares Three Years Ago You Would Be Down 16%

Opbrengsten en kosten

Hoe Paul Hartmann geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

DB:PHH2 Opbrengsten, kosten en inkomsten (EUR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 242,398607720
31 Mar 242,383447670
31 Dec 232,367287620
30 Sep 232,365267540
30 Jun 232,363237450
31 Mar 232,342307380
31 Dec 222,320367310
30 Sep 222,300467280
30 Jun 222,281567250
31 Mar 222,296757260
31 Dec 212,311957270
30 Sep 212,335997250
30 Jun 212,3591037230
31 Mar 212,4001057180
31 Dec 202,4401067130
30 Sep 202,397997020
30 Jun 202,354926920
31 Mar 202,274756860
31 Dec 192,194586800
30 Sep 192,179666870
30 Jun 192,163746940
31 Mar 192,144766860
31 Dec 182,125796790
30 Sep 182,109826720
30 Jun 182,093846640
31 Mar 182,078866580
31 Dec 172,063886530
30 Sep 172,043876490
30 Jun 172,024856460
31 Mar 172,007856390
31 Dec 161,991856310
30 Sep 161,978846160
30 Jun 161,964846020
31 Mar 161,955815980
31 Dec 151,946795940
30 Sep 151,929775900
30 Jun 151,912755850
31 Mar 151,889745790
31 Dec 141,866745730
30 Sep 141,842695620
30 Jun 141,818655500
31 Mar 141,807615480
31 Dec 131,797575470

Kwaliteitswinsten: PHH2 heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (2.5%) PHH2 } zijn hoger dan vorig jaar (1%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van PHH2 is de afgelopen 5 jaar met 17.7% per jaar gedaald.

Versnelling van de groei: De winstgroei van PHH2 over het afgelopen jaar ( 156.1% ) overtreft het 5-jarig gemiddelde ( -17.7% per jaar).

Winst versus industrie: De winstgroei PHH2 over het afgelopen jaar ( 156.1% ) overtrof de Medical Equipment -sector 16.2%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 5.7% ) van PHH2 wordt als laag beschouwd.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y